Cited by 184Genetic Associations and EpidemiologyDiabetes, Cardiovascular Risks, and LipoproteinsNutrition, Genetics, and Disease

BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization

Open access
Corbin, Laura J., Richmond, Rebecca C., Wade, Kaitlin H., Burgess, Stephen, Bowden, Jack, Smith, George Davey, Timpson, Nicholas J.·2016·Diabetes

Abstract

This study focused on resolving the relationship between BMI and type 2 diabetes. The availability of multiple variants associated with BMI offers a new chance to resolve the true causal effect of BMI on type 2 diabetes; however, the properties of these associations and their validity as genetic instruments need to be considered alongside established and new methods for undertaking Mendelian randomization (MR). We explore the potential for pleiotropic genetic variants to generate bias, revise existing estimates, and illustrate value in new analysis methods. A two-sample MR approach with 96 genetic variants was used with three different analysis methods, two of which (MR-Egger and the weighted median) have been developed specifically to address problems of invalid instrumental variables. We estimate an odds ratio for type 2 diabetes per unit increase in BMI (kg/m2) of between 1.19 and 1.38, with the most stable estimate using all instruments and a weighted median approach (1.26 [95% CI 1.17, 1.34]). TCF7L2(rs7903146) was identified as a complex effect or pleiotropic instrument, and removal of this variant resulted in convergence of causal effect estimates from different causal analysis methods. This indicated the potential for pleiotropy to affect estimates and differences in performance of alternative analytical methods. In a real type 2 diabetes–focused example, this study demonstrates the potential impact of invalid instruments on causal effect estimates and the potential for new approaches to mitigate the bias caused.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db16-0418

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [30]Office of National Statistics(UK) Annual Mid-year Population Estimates, 2013 Statistical bulletin 2014

Cited by

Sorted by citations

Authors
Corbin, L. J., Richmond, R. C., Wade, K. H., Burgess, S., Bowden, J., Smith, G. D., & Timpson, N. J.
Affiliations
  • University of Bristol (GB)
  • University of Cambridge (GB)
Corresponding author
Timpson, Nicholas J.
Venue
Diabetes
Published
2016-07-08
Volume
65
Issue
10
Pages
3002-3007
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2475125285
Cited by
184
References
33
Citations by year
2026: 18 · 2025: 15 · 2024: 19 · 2023: 14 · 2022: 15 · 2021: 21 · 2020: 25 · 2019: 15 · 2018: 20 · 2017: 17 · 2016: 5
FWCI
15.35
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Bristol Research (University of Bristol) (acceptedVersion, cc-by-nc)
  • Apollo (University of Cambridge) (acceptedVersion)
  • Apollo
Funders
  • Medical Research Council (MC_UU_12013/1, MC_UU_12013/2, MC_UU_12013/3, MR/N501906/1)
  • Cancer Research UK (C18281/A19169)
  • Wellcome Trust (100114)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
Keywords
body mass index, type 2 diabetes, pleiotropy, genetic instruments, TCF7L2, MR-Egger, weighted median, two-sample Mendelian randomization, assessment validity
MeSH terms
Diabetes Mellitus, Type 2, Humans, Risk Factors, Body Mass Index, Odds Ratio, Genetic Predisposition to Disease, Mendelian Randomization Analysis, Transcription Factor 7-Like 2 Protein, Genetic Pleiotropy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review